Glucagon-like peptide-1 (GLP-1) is a gut-derived hormone secreted by L-cells after food intake. It enhances insulin release, suppresses glucagon, reduces appetite, and improves glucose metabolism. Via the GLP-1 receptor, it activates intracellular signaling pathways (cAMP, calcium), supporting cardiovascular, hepatic, neurological, and gastrointestinal health. GLP-1 analogs and dual agonists like tirzepatide are used to manage type 2 diabetes, obesity, fatty liver disease, and neurodegeneration by reducing inflammation and oxidative stress.
Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about OZEMPIC by Novo Nordisk, consult with your doctor or healthcare professional.
Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology
Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology
Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology
Home
